• Opinion: Needed: a clearer explanation of why diversity in clinical trials is important

    4 days ago - By STAT

    Increasing the diversity of clinical trial participants is all the rage these days. The numbers tell the story: According to Food and Drug Administration data , in 2020 75% of trial participants were white, 11% were Hispanic, 8% were Black, and 6% were Asian. Given those numbers, regulators and sponsors are trying to broaden the recruitment of people from different racial and ethnic groups.
    But one thing is missing: a clear explanation of why this is important.
    Read more ...